Lupin Launches Generic ZYMAXID™ Ophthalmic Solution in the US
Lupin Launches Generic ZYMAXID™ Ophthalmic Solution in the US
Filed under: drug treatment centers in baltimore
Lupin had earlier received final approval from the United States Food and Drugs Administration (US FDA) to market a generic version of Allergan Inc.'s Zymaxid™ Ophthalmic Solution, 0.5%. Lupin's Gatifloxacin Ophthalmic solution 0.5% is the generic …
Read more on SYS-CON Media (press release)
Plan to stop TB in kids overdue but problematic
Filed under: drug treatment centers in baltimore
He was one of the authors of a strategy issued Tuesday by many health and advocacy groups, including the World Health Organization, UNICEF, and the U.S. Centers for Disease Control and Prevention. The plan identifies 10 priorities, including treating …
Read more on Fox Baltimore
Cancer report describes 'amazing progress,' urges more funding
Filed under: drug treatment centers in baltimore
… director of the cancer immunology program at the Johns Hopkins Kimmel Comprehensive Cancer Center and a contributor to the report, described a number of advances in the field that had occurred in the last two to three years, including the FDA …
Read more on Los Angeles Times
Battle against sickle cell disease has local roots [Ellicott City]
Filed under: drug treatment centers in baltimore
"Even though SCD is the oldest genetic disorder known, there is only one drug approved in the United States for its treatment. This drug does not work for all patients and patients, like our son, who take it, must be monitored constantly to guard …
Read more on Baltimore Sun (blog)